Page 2 of 4
1234

Vincent MJ, Fitch S, Bylsma L, Thompson C, Rogers S, Britt J, Wikoff D. 2024. Assessment of associations between inhaled formaldehyde and lymphohematopoietic cancer through the integration of epidemiological and toxicological evidence with biological plausibility. Toxicol Sci 199(2):172–193; open access.

View Abstract

Blatt AZ, Suh M, Walter EB Jr, Wood CT, Espinosa C, … Movva N, Reichert H, Fryzek JP, Nelson CB. 2024. Geographic progression of infant respiratory syncytial virus associated bronchiolitis across the United States before and since the onset of COVID-19: Results from four health systems, 2015-2023. Influenza Other Respir Viruses 18(5):e13298; doi: 10.1111/irv.13298.

View Abstract

Blatt AZ, Suh M, Walter EB Jr, Wood CT, Espinosa C, … Movva N, Reichert H, Fryzek JP, Nelson CB. 2024. Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023. Ann Epidemiol 94:72–80; open access.

View Abstract

Wikoff D, Fitch S. 2024. Evidence‐based methods in toxicology: Systematic review and systematic evidence mapping. Chapter 32 in: Paustenbach DJ (ed), Human and Ecological Risk Assessment: Theory and Practice, Third Edition, pp. 1133–1148. Wiley, ISBN: 978-1-119-74296-8.

Mihalchik AL, Choksi NY, Roe AL, Wisser M, Whitaker K, Seibert D, Deore M, Pavlick L, Wikoff DS. 2024. Safety evaluation of 8 drug degradants present in over-the-counter cough and cold medications. Regul Toxicol Pharmacol 149:105621; doi: 10.1016/j.yrtph.2024.105621.

View Abstract

Yoshino T, Hooda N, Younan D, Muro K, Shitara K, Heinemann V,… Suh M, Reichert H, et al. 2024. A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness. Eur J Cancer 202:113975, doi: 10.1016/j.ejca.2024.113975.

View Abstract

Nelms MD, Antonijevic T, Ring C, Harris DL, Bever RJ, Lynn SG, … Borghoff S, et al. 2024. Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models. Front Toxicol 6:1346767; https://doi.org/10.3389/ftox.2024.1346767.

View Abstract

Mittal L, Perry C, Blanchette AD, Proctor DM. 2024. Probabilistic risk assessment of residential exposure to electric arc furnace steel slag using Bayesian model of relative bioavailability and PBPK modeling of manganese. Risk Analysis, open access.

View Abstract

Suh M, Movva N, Jiang X, Reichert H, Pastula ST, Sacks NC, Frankenfeld C, Fryzek JP, Simões AF. 2024. Healthcare utilization among infants covered by Medicaid and newly diagnosed with respiratory syncytial virus. Open Forum Infect Dis, open access.

View Abstract

Heintz MM, Klaren WD, East AW, Haws LC, McGreal SR, Campbell RR, Thompson CM. 2024. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in mouse, rat, and pooled human hepatocytes. Toxicol Sci 200(1):165–182; doi: 10.1093/toxsci/kfae044.  PMID: 38574381

View Abstract
Page 2 of 4
1234